• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
departures sign at airport
Biotech

AZ pauses $271M UK expansion as British backtrack continues

The investment was meant to fund a facility near AstraZeneca’s Cambridge headquarters that would have employed around 1,000 people.
Darren Incorvaia Sep 12, 2025 2:44pm
Lilly

Eli Lilly reconsiders UK biotech incubator

Sep 12, 2025 12:09pm
FDA
Favicon Fierce Pharma

Under Trump, FDA seeks to abandon expert reviews of new drugs

Sep 12, 2025 9:50am
Neurescue device smart balloon catheter

Neurescue nets European approval in non-shockable cardiac arrest

Sep 12, 2025 2:00pm
Masimo SedLine

Philips, Masimo re-up patient monitor partnership with AI focus

Sep 12, 2025 12:00pm
brain

Galimedix’s oral Alzheimer’s candidate clears ph. 1 safety test

Sep 12, 2025 11:11am
More News

Takeda taps longtime Lilly exec as US head—Chutes & Ladders

Sep 12, 2025 8:30am
Fierce Pharma

Nominations open for Fiercest Women in Life Sciences 2025

Sep 12, 2025 7:00am
Fierce Pharma

Novo Nordisk tells employees they must return to office Jan. 1

Sep 11, 2025 2:13pm

Custom gene editor fixes mutation causing deadly disease in mice

Sep 11, 2025 1:48pm
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings